NovaBridge Biosciences

NBPNASDAQHealthcare● Active

$1.62

+$0.06(+3.53%)

Market Cap$186154676

P/E Ratio—

52W High$6.79

52W Low$1.53

Avg Volume1.0M

Open$1.61

Beta1.48

Overview

NovaBridge Biosciences (NBP) Earnings: Dates, EPS & Revenue History

Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.

NBP · earnings · updated Jun 9, 2026

Latest Earnings

Q2 FY2026Report Date: Apr 7, 2026

EPS Actual

-$0.03

Est. -$0.01 · -528.1%

Revenue

—

Fiscal Period

Q2 FY2026

FY ends December

Report Date

Apr 7, 2026

After Market Close

▼ Miss EPS

NBP reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.

Next Earnings Date

Days Away

days

Expected Date

Sep 1, 2026

Fiscal Period

Q3 FY2026

Release Time

◌ Time TBD (Unconfirmed)

EPS Est.

—

Days Away84

Expected DateSep 1, 2026

Fiscal PeriodQ3 FY2026

Release TimeTime TBD (Unconfirmed)

EPS Est.—

EPS & Revenue vs. Estimates

Actual (Beat)

Actual (Miss)

Estimated

Earnings History

Period	Report Date	EPS Est.	EPS Actual	EPS Surpr.	Revenue	Rev. Est.	Rev. Surpr.
◌ Q3 FY2026	Sep 1, 2026	-$0.02	—	—	—	—	—
◌ Q2 FY2026	Jun 30, 2026	-$0.01	—	—	—	—	—
▼ Q2 FY2026	Apr 7, 2026	-$0.01	-$0.03	-528.1%	—	—	—
▼ Q4 FY2025	Dec 18, 2025	-$0.01	-$0.25	-1801.1%	—	—	—
▲ Q4 FY2025	Nov 12, 2025	-$0.04	-$0.01	+76.5%	—	—	—
▲ Q2 FY2025	May 15, 2025	-$0.06	-$0.04	+33.3%	—	—	—
▼ Q2 FY2025	Apr 4, 2025	-$0.06	-$0.11	-83.3%	—	$0.00B	—
▼ Q4 FY2024	Nov 14, 2024	-$0.16	-$0.25	-56.3%	—	—	—

Q3 FY2026

Sep 1, 2026

EPS Actual

—

EPS Est.

-$0.02

EPS Surpr.

—

Revenue

—

Q2 FY2026

Jun 30, 2026

EPS Actual

—

EPS Est.

-$0.01

EPS Surpr.

—

Revenue

—

Q2 FY2026

Apr 7, 2026Miss

EPS Actual

-$0.03

EPS Est.

-$0.01

EPS Surpr.

-528.1%

Revenue

—

Q4 FY2025

Dec 18, 2025Miss

EPS Actual

-$0.25

EPS Est.

-$0.01

EPS Surpr.

-1801.1%

Revenue

—

Q4 FY2025

Nov 12, 2025Beat

EPS Actual

-$0.01

EPS Est.

-$0.04

EPS Surpr.

+76.5%

Revenue

—

Q2 FY2025

May 15, 2025Beat

EPS Actual

-$0.04

EPS Est.

-$0.06

EPS Surpr.

+33.3%

Revenue

—

Q2 FY2025

Apr 4, 2025Miss

EPS Actual

-$0.11

EPS Est.

-$0.06

EPS Surpr.

-83.3%

Revenue

—

Q4 FY2024

Nov 14, 2024Miss

EPS Actual

-$0.25

EPS Est.

-$0.16

EPS Surpr.

-56.3%

Revenue

—

Analyst Estimates

Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.

EPS Estimates

Period	Low	Consensus	High	# Analysts
Q4 FY2026	$-0.83	$-0.83	$-0.83	1
Q3 FY2026	$-0.89	$-0.89	$-0.89	1
Q2 FY2026	$-0.83	$-0.83	$-0.83	1
Q1 FY2026	$-0.76	$-0.76	$-0.76	1
Q4 FY2025	$-0.30	$-0.24	$-0.19	2
Q3 FY2025	$-0.76	$-0.66	$-0.47	2

Revenue Estimates

Period	Low	Consensus	High
Q4 FY2026	$0.0B	$0.0B	$0.0B
Q3 FY2026	$0.0B	$0.0B	$0.0B
Q2 FY2026	$0.0B	$0.0B	$0.0B
Q1 FY2026	$0.0B	$0.0B	$0.0B
Q4 FY2025	$0.0B	$0.0B	$0.0B
Q3 FY2025	$0.0B	$0.0B	$0.0B

Earnings Price Reaction

Closing price one trading day before vs. one trading day after each earnings release.

Period	Report Date	EPS Beat/Miss	Price Before	Price After	1D Reaction
▼ Q2 FY2026	Apr 7, 2026	-528.1%	$2.42	$2.48	+2.48%
▼ Q4 FY2025	Dec 18, 2025	-1801.1%	$4.13	$3.96	-4.12%
▲ Q4 FY2025	Nov 12, 2025	+76.5%	$4.23	$4.22	-0.24%
▲ Q2 FY2025	May 15, 2025	+33.3%	$0.88	$0.89	+0.31%
▼ Q2 FY2025	Apr 4, 2025	-83.3%	$0.73	$0.68	-6.86%
▼ Q4 FY2024	Nov 14, 2024	-56.3%	$1.04	$1.07	+2.88%
▲ Q3 FY2024	Aug 28, 2024	+86.3%	$1.26	$1.17	-7.14%
— Q2 FY2024	Jun 5, 2024	—	$1.88	$1.90	+1.06%

Q2 FY2026+2.48%

Report Date

Apr 7, 2026

EPS Beat/Miss

-528.1%

Price Before

$2.42

Price After

$2.48

Q4 FY2025-4.12%

Report Date

Dec 18, 2025

EPS Beat/Miss

-1801.1%

Price Before

$4.13

Price After

$3.96

Q4 FY2025-0.24%

Report Date

Nov 12, 2025

EPS Beat/Miss

+76.5%

Price Before

$4.23

Price After

$4.22

Q2 FY2025+0.31%

Report Date

May 15, 2025

EPS Beat/Miss

+33.3%

Price Before

$0.88

Price After

$0.89

Q2 FY2025-6.86%

Report Date

Apr 4, 2025

EPS Beat/Miss

-83.3%

Price Before

$0.73

Price After

$0.68

Q4 FY2024+2.88%

Report Date

Nov 14, 2024

EPS Beat/Miss

-56.3%

Price Before

$1.04

Price After

$1.07

Q3 FY2024-7.14%

Report Date

Aug 28, 2024

EPS Beat/Miss

+86.3%

Price Before

$1.26

Price After

$1.17

Q2 FY2024+1.06%

Report Date

Jun 5, 2024

EPS Beat/Miss

—

Price Before

$1.88

Price After

$1.90

Avg Beat Reaction-2.36%

Avg Miss Reaction-1.41%

Beat Rate3 / 8 quarters

Largest Move-7.14% (Q3 FY2024)

Data: FMP /historical-price-eod/full · field: close

About Earnings & Data Methodology

NovaBridge Biosciences (NBP) most recently reported earnings on April 7, 2026 for Q2 FY2026, posting EPS of $-0.03 — missing the analyst consensus of $-0.01 by -528.1%. The next NBP earnings date is expected around September 1, 2026.

Each quarter, investors track NBP earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. NBP revenue tab →

Earnings Glossary

EPS (Earnings Per Share)

Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.

Earnings Surprise %

(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.

Beat / Miss / In-Line

Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.

BMO / AMC

Before Market Open / After Market Close. Two windows when companies typically release results.

Fiscal Quarter

NBP's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.

Analyst Consensus

Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.

Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.

Revenue Price history Financial statements Forecast Dividends Market cap

Frequently asked questions

NBP earnings · 5 questions

NovaBridge Biosciences's next earnings report is expected around September 1, 2026. NBP typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; NBP historically reports after market close (AMC).

NBP earnings datewhen is NBP earningsNBP next earnings datewhen does NBP report earningsNBP earnings calendar

▸ Source: FMP · NovaBridge Biosciences SEC filings · US GAAP · NovaBridge Biosciences SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026